NASDAQ: INNV
Innovage Holding Corp Stock

$3.96+0.16 (+4.21%)
Updated May 13, 2025
INNV Price
$3.96
Fair Value Price
-$3.13
Market Cap
$534.65M
52 Week Low
$2.60
52 Week High
$6.69
P/E
-16.5x
P/B
2.25x
P/S
0.48x
PEG
N/A
Dividend Yield
N/A
Revenue
$831.68M
Earnings
-$31.23M
Gross Margin
17.9%
Operating Margin
-2.99%
Profit Margin
-3.8%
Debt to Equity
1.13
Operating Cash Flow
$26M
Beta
1.16
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

INNV Overview

InnovAge Holding Corp. offers services to seniors who require support to live independently in their homes and communities. It's in-home care services include skilled, unskilled, and personal care. The company also provides in-center services (primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services), meals, activities, and transportation to its centers and third-party medical appointments. InnovAge was founded in 2007 and is headquartered in Denver, CO.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine INNV's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Care Facility

Industry Rating
A
INNV
Ranked
#29 of 43

Top Ranked Stocks in Industry

View Top Medical Care Facility Stocks

Be the first to know about important INNV news, forecast changes, insider trades & much more!

INNV News

Overview

Due Diligence Score

Industry Average (29)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how INNV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

INNV ($3.96) is overvalued by 226.47% relative to our estimate of its Fair Value price of -$3.13 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
INNV ($3.96) is not significantly undervalued (226.47%) relative to our estimate of its Fair Value price of -$3.13 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
INNV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more INNV due diligence checks available for Premium users.

Valuation

INNV fair value

Fair Value of INNV stock based on Discounted Cash Flow (DCF)

Price
$3.96
Fair Value
-$3.13
Undervalued by
226.47%
INNV ($3.96) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
INNV ($3.96) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
INNV is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

INNV price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-16.5x
Industry
16.38x
Market
25.53x

INNV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.25x
Industry
4.54x
INNV is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

INNV's financial health

Profit margin

Revenue
$218.1M
Net Income
-$11.4M
Profit Margin
-5.2%
INNV's Earnings (EBIT) of -$24.84M... subscribe to Premium to read more.
Interest Coverage Financials
INNV's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$536.6M
Liabilities
$268.9M
Debt to equity
1.13
INNV's short-term liabilities ($225.32M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
INNV's short-term assets ($176.18M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
INNV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$24.6M
Investing
-$8.1M
Financing
-$2.1M
INNV's operating cash flow ($25.74M)... subscribe to Premium to read more.
Debt Coverage Financials

INNV vs Medical Care Facility Stocks

TickerZen RatingMarket Cap1d %P/EP/B
INNVC$534.65M+4.21%-16.50x2.25x
CYHC$533.16M-1.55%-1.04x-0.28x
EHABA$530.17M+0.10%-3.79x0.98x
AUNAB$509.66M-0.58%15.35x1.26x
SNDAC$509.55M-0.44%-8.71x8.67x

Innovage Holding Stock FAQ

What is Innovage Holding's quote symbol?

(NASDAQ: INNV) Innovage Holding trades on the NASDAQ under the ticker symbol INNV. Innovage Holding stock quotes can also be displayed as NASDAQ: INNV.

If you're new to stock investing, here's how to buy Innovage Holding stock.

What is the 52 week high and low for Innovage Holding (NASDAQ: INNV)?

(NASDAQ: INNV) Innovage Holding's 52-week high was $6.69, and its 52-week low was $2.60. It is currently -40.81% from its 52-week high and 52.31% from its 52-week low.

How much is Innovage Holding stock worth today?

(NASDAQ: INNV) Innovage Holding currently has 135,012,952 outstanding shares. With Innovage Holding stock trading at $3.96 per share, the total value of Innovage Holding stock (market capitalization) is $534.65M.

Innovage Holding stock was originally listed at a price of $24.20 in Mar 4, 2021. If you had invested in Innovage Holding stock at $24.20, your return over the last 4 years would have been -83.64%, for an annualized return of -36.4% (not including any dividends or dividend reinvestments).

How much is Innovage Holding's stock price per share?

(NASDAQ: INNV) Innovage Holding stock price per share is $3.96 today (as of May 13, 2025).

What is Innovage Holding's Market Cap?

(NASDAQ: INNV) Innovage Holding's market cap is $534.65M, as of May 14, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Innovage Holding's market cap is calculated by multiplying INNV's current stock price of $3.96 by INNV's total outstanding shares of 135,012,952.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.